COMPARATIVE EFFICACY OF PRE-EXTUBATION LIGNOCAINE VS NALBUPHINE IN ATTENUATION OF THE STRESS RESPONSE TO EMERGENCE OF GENERAL ANESTHESIA IN HYPERTENSIVE PATIENTS: A DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL
Abstract
Background: Tracheal extubation during emergence from general anesthesia induces a profound reflex sympathetic response characterized by transient hypertension, tachycardia, and increased catecholamine secretion 1. In patients with underlying essential hypertension, these abrupt hemodynamic fluctuations significantly escalate the risk of acute myocardial ischemia, malignant arrhythmias, ventricular dysfunction, and cerebrovascular accidents 2, 3. Pharmacological attenuation of airway reflexes and sympathetic activation is therefore essential during peri-extubation care 4, 5.
Objective: To evaluate and compare the clinical efficacy of intravenous lignocaine versus intravenous nalbuphine administered pre-extubation in suppressing the hemodynamic stress response, emergence coughing, and agitation in hypertensive patients undergoing elective surgery under general anesthesia.
Methodology: A double-blind, randomized controlled trial was conducted among 40 elective surgical patients aged 20–65 years with controlled essential hypertension (ASA physical status II–III). Patients were randomly assigned into two equal groups (n = 20 each): Group L received intravenous lignocaine 1.5 mg/kg and Group N received intravenous nalbuphine 0.05 mg/kg, each diluted to 10 mL and administered slowly 2–3 minutes prior to tracheal extubation. Standardized general anesthesia and neuromuscular reversal protocols were maintained across both cohorts. Hemodynamic variables—including Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), and Mean Arterial Pressure (MAP)—were documented at baseline (T0), pre-study drug (T1), extubation (T2), 1 minute post-extubation (T3), and 3 minutes post-extubation (T4). Secondary outcomes evaluated included cough reflex severity (4-point scale), Riker Sedation-Agitation Scale (SAS) scores, extubation time, and adverse events 10, 11, 12. Statistical analyses were performed using independent t-tests, Mann-Whitney U tests, and Chi-square tests 10.
Results: Both groups were statistically comparable regarding demographic variables and baseline hemodynamic status (p > 0.05). At the moment of extubation (T2), Group N displayed significantly lower Mean Arterial Pressure (108.00 ± 4.47 mmHg vs 113.10 ± 4.81 mmHg; p = 0.0013) and Heart Rate (80.70 ± 5.25 bpm vs 85.20 ± 5.90 bpm; p = 0.0150) compared to Group L. At 1 minute post-extubation (T3), MAP remained markedly lower in Group N (105.65 ± 4.51 mmHg vs 110.50 ± 4.76 mmHg; p = 0.0021). Emergence cough reflex scores were significantly reduced in Group N (0.85 ± 0.59) compared to Group L (1.85 ± 0.59; p < 0.0001), with 25% of patients in Group N demonstrating complete absence of coughing (Grade 0) versus 0% in Group L. Group N also demonstrated significantly lower Riker SAS scores (3.50 ± 0.51 vs 4.85 ± 0.59; p < 0.0001), indicating a calm, smooth emergence without emergence delirium. No significant differences were observed in extubation time (143.30 ± 11.23 s vs 147.70 ± 11.41 s; p = 0.2266) or adverse event rates, and zero episodes of respiratory depression occurred.
Conclusion: Pre-extubation administration of low-dose intravenous nalbuphine (0.05 mg/kg) is superior to intravenous lignocaine (1.5 mg/kg) in attenuating hemodynamic pressor responses, blunting emergence cough, and promoting smooth, agitation-free emergence in hypertensive patients without delaying extubation or causing adverse effects.
Keywords
- General Anesthesia, Tracheal Extubation, Essential Hypertension, Lignocaine, Nalbuphine, Hemodynamic Stress Response, Emergence Cough.
Views & Downloads Statistics (Last 12 Months)
Monthly performance and trends of article views and downloads
